Switch to:
More From Other Websites
Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? Jul 23 2014
Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? Jul 23 2014
Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts Jul 22 2014
European shares bounce back, helped by earnings reports Jul 22 2014
European shares bounce back as Ukraine tension ease Jul 22 2014
European shares up as Ukraine rebels allow improved access Jul 22 2014
Neil Woodford’s Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco Group PLC Jul 22 2014
Neil Woodford's Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco Group PLC Jul 22 2014
European shares rebound as Ukraine rebels hand over black boxes Jul 22 2014
MedImmune and Advaxis partner on immuno-oncology combination clinical trial Jul 22 2014
AstraZeneca widens cancer immunotherapy net with Advaxis trial Jul 22 2014
Allergan Beats on Q2 Earnings, Ups View & Plans 13% Job Cut Jul 21 2014
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise Jul 21 2014
How AstraZeneca plc Can Pay Off Your Mortgage Jul 21 2014
How AstraZeneca plc Can Pay Off Your Mortgage Jul 21 2014
How to turn the strong pound to your advantage Jul 19 2014
US giant AbbVie buys drugmaker Shire for $54bn Jul 18 2014
Shire Agrees to AbbVie $55B Takeover Offer Jul 18 2014
Drugmakers announce tax-cutting merger Jul 18 2014
Pep Boys, Buenaventura, Pfizer, Mylan and AstraZeneca highlighted as Zacks Bull and Bear of the Day Jul 18 2014
Shire Agrees To £32bn AbbVie Takeover Deal Jul 18 2014
Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK Jul 18 2014
Broker tips: GlaxoSmithKline, AstraZeneca, Housebuilders Jul 17 2014
Market overview: RBS says taxpayer will make money back in selloff Jul 17 2014
Ex-Cadbury Chair Warns On Cable Takeover Plan Jul 17 2014
AbbVie, Shire set to announce merger as early as Friday: report Jul 17 2014
UPDATE 1-Shire, AbbVie to announce $53 bln merger by Friday -sources Jul 17 2014
Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program Jul 17 2014
Eli Lilly and Immunocore Collaborate to Develop Cancer Drugs Jul 17 2014
Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz Jul 17 2014
AstraZeneca unveils plans for 'see-through' labs in Cambridge Jul 17 2014
Shire, AbbVie to announce $53 billion merger by Friday -sources Jul 17 2014
3 Health Care Stocks Dragging The Sector Down Jul 17 2014
White House Push to Stop U.S. Companies Moving Overseas Unlikely to Bear Fruit Jul 17 2014
Pfizer Bolsters Injectables by Buying InnoPharma Jul 17 2014
Murdoch slams US push to block firms moving overseas for lower taxes Jul 17 2014
Market report: easyJet shares take off Jul 16 2014
Slim chances seen for tax 'inversion' clampdown, analysts say Jul 16 2014
One Reason Why AstraZeneca plc Is A Risky Bet Jul 16 2014
Will Congress Block Tax Inversions? Jul 16 2014
With Tips From Pfizer, AbbVie Lands the Biggest Pharma Deal of the Year: StockTwits Jul 15 2014
Walgreen 3Q profit jumps but misses expectations Jun 24 2014
New study aims to rapidly test lung cancer drugs Jun 17 2014
BofA and Hillshire are big market movers May 27 2014
Nonprescription Nexium heartburn medicine launches May 27 2014
AstraZeneca rejects $119 billion offer from Pfizer May 19 2014
AstraZeneca and AT&T are big market movers May 19 2014
AstraZeneca board rejects new offer from Pfizer May 19 2014
Pfizer raises offer, highlighting flurry of deals May 19 2014
Pfizer ups offer for AstraZeneca again, to $119B May 19 2014
AstraZeneca fends off Pfizer with new growth plan May 06 2014
Pfizer 1Q profit drops 15 pct due to lower sales May 05 2014
Pfizer mulls options after AstraZeneca snubs offer May 05 2014
Stock futures slide after weak Chinese data May 05 2014
AstraZeneca rejects sweetened Pfizer takeover bid May 02 2014
Pfizer sweetens bid for AstraZeneca May 02 2014
Bristol-Myers profit up 54 pct. on cost cuts, sale Apr 29 2014
Bank of America, AstraZeneca are big market movers Apr 28 2014
Pfizer still pursuing AstraZeneca after 2nd rebuff Apr 28 2014
AstraZeneca shares soar on Pfizer interest Apr 28 2014
AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K. (Japan) Mar 26 2014
Forxiga® receives regulatory approval in Japan for the treatment of type 2 diabetes Mar 24 2014
AstraZeneca proposes appointment of Ann Cairns as Non-Executive Director Mar 20 2014
AstraZeneca announces sale of Alderley Park site in Cheshire, UK Mar 12 2014
US FDA approves Bydureon® Pen (exenatide extended-release for injectable suspension) for... Mar 03 2014
US FDA approves orphan drug MYALEPT™ (metreleptin for injection) Feb 25 2014
AstraZeneca profits heading south as patent losses bite Feb 06 2014
AstraZeneca PLC fourth quarter and full year results 2013 Feb 06 2014
AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance Feb 03 2014
AstraZeneca to shut R&D centre in Bangalore Jan 29 2014
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance Provides $5 Million Grant for American... Jan 16 2014
AstraZeneca provides update at JP Morgan Healthcare Conference on progress to achieve scientific... Jan 14 2014
AstraZeneca and Bristol-Myers Squibb announce US FDA approval of FARXIGA™ (dapagliflozin) Jan 08 2014
AstraZeneca and Bristol-Myers Squibb Announce U.S. FDA Approval of Farxiga™ (dapagliflozin) Jan 08 2014
MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies Jan 08 2014
AstraZeneca and Shionogi settle arbitration and extend licence agreement for CRESTOR® Dec 27 2013
Shionogi Extends License Agreement and Settles Arbitration with AstraZeneca for Crestor® Dec 25 2013
AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets Dec 19 2013
AstraZeneca takes control of diabetes venture for $4.1bn Dec 18 2013
AstraZeneca statement in response to reports of a launch of esomeprazole strontium product in the US Dec 17 2013


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide